Discontinuation of oral anticoagulant use among nursing home residents with atrial fibrillation before hospice enrollment
Journal of the American Geriatrics Society · 2023
DOI: 10.1111/jgs.18512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, 2023. Verfasst von Qiaoxi Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Population Health Research Program, Graduate School of Biomedical Sciences, University of Massachusetts Chan Medical School, Worcester, …. Hauptthemen laut MEDLINE: Atrial Fibrillation, Hospice Care, Hospices, Stroke. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Themen: Langzeitpflege, Palliativpflege
Abstract (Originalsprache)
Background
Oral anticoagulants (OACs) are effective in reducing the risk of cardioembolic stroke due to atrial fibrillation. While most nursing home residents with atrial fibrillation qualify for anticoagulation based on clinical guidelines, the net clinical benefits of OACs may diminish as residents approach the end of life.
Methods
We conducted a cross‐sectional study of 30,503 US nursing home residents with atrial fibrillation (based on Minimum Data Set 3.0 and Medicare Part A records) who used OACs in the year before enrolling in hospice care during 2012–2016. Whether residents discontinued OACs before hospice enrollment was determined using Part D claims and date of hospice enrollment. Modified Poisson models estimated adjusted prevalence ratios (aPR).
Results
Almost half (45.7%) of residents who had recent OAC use discontinued prior to hospice enrollment. Residents who were underweight (aPR: 1.02; 95% confidence interval [CI]: 1.01–1.03), those with high bleeding risk (aPR: 1.04, 95% CI: 1.03–1.05), and those with moderate or severe cognitive impairment (aPR: 1.02, 95% CI: 1.02–1.03) had a higher prevalence of OAC discontinuation before entering hospice. Residents with venous thromboembolism (aPR: 0.94, 95% CI: 0.93–0.96), statin users (aPR: 0.88, 95% CI: 0.87–0.89), and those on polypharmacy (≥10 medications, aPR: 0.72; 95% CI: 0.71–0.73) were less likely to discontinue OACs before enrollment in hospice.
Conclusion
Anticoagulants are often discontinued among older nursing home residents with atrial fibrillation before hospice enrollment; it is not clear that these decisions are driven solely by net clinical benefit considerations. Further research is needed on comparative outcomes to inform resident‐centered decisions regarding OAC use in older adults entering hospice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Population Health Research Program, Graduate School of Biomedical Sciences, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
- Division of Epidemiology, Department of Population and Quantitative Health Services, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
ORCID-Profile: Qiaoxi Chen, Kate Lapane
Förderung
- NIA NIH HHS
Zitieren
APA
Chen, Q., Baek, J., Goldberg, R., Tjia, J., Lapane, K., & Alcusky, M. (2023). Discontinuation of oral anticoagulant use among nursing home residents with atrial fibrillation before hospice enrollment. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.18512
Vancouver
Chen Q, Baek J, Goldberg R, Tjia J, Lapane K, Alcusky M. Discontinuation of oral anticoagulant use among nursing home residents with atrial fibrillation before hospice enrollment. Journal of the American Geriatrics Society. 2023. doi:10.1111/jgs.18512
BibTeX
@article{Chen2023,
author = {Chen, Qiaoxi and Baek, Jonggyu and Goldberg, Robert and Tjia, Jennifer and Lapane, Kate and Alcusky, Matthew},
title = {Discontinuation of oral anticoagulant use among nursing home residents with atrial fibrillation before hospice enrollment},
journal = {Journal of the American Geriatrics Society},
year = {2023},
doi = {10.1111/jgs.18512}
}
EUVIMED